Outsourcing-Pharma

Can't read the email below? Click Here

Today on Outsourcing-Pharma.com

>	Managing clinical risk in Eastern Europe
>	Diosynth bags cardiovascular drug deal
>	ClinPhone buys DataLabs to dominate sector
>	Aptuit continues service expansion
>	VirtualScopics signs $1.7m osteoarthritis trial contract

Other top industry news

>	Novartis splashes the cash in Asia
>	MSD invests €100m in Irish drug making arm
>	Researchers use bacteria to make anti-cancer drugs
>	Sigma-Aldrich launches first commercially available proteomics standard

	Outsourcing Pharma

Search Forward to a colleague		Wednesday 08 November 2006

Sponsored by Cardinal Health
Cardinal Health enhances drug delivery
Cardinal Health is a world leader in patented drug-delivery technologies. We develop and manufacture advanced drug-delivery systems and partner with nearly every major global pharmaceutical company. Click Here

Access full stories

Managing clinical risk in Eastern Europe
Running clinical trials in Eastern Europe has its pros and cons - two industry veterans from Parexel discuss how best to manage the risks... Read

Diosynth bags cardiovascular drug deal
Diosynth Biotechnology has bagged a deal for the process development, scale-up, and clinical manufacturing of Viron Therapeutics lead compound... Read

ClinPhone buys DataLabs to dominate sector
eClinical services provider ClinPhone has bought electronic data capture (EDC) vendor DataLabs in a bid to dominate the sector... Read

Aptuit continues service expansion
Aptuit has announced its intention to acquire SSCI, a leading solid state chemistry company, just weeks after it bought the pharmaceutical services division of technology firm EaglePicher... Read

VirtualScopics signs $1.7m osteoarthritis trial contract
VirtualScopics has signed a $1.7m (€1.3m) contract with a pharmaceutical company, which aims to investigate a disease-modifying agent for osteoarthritis... Read

All News Headlines for: November | October | September

Sponsored by ScinoPharm Taiwan®
Experts in small molecule custom synthesis
ScinoPharm Taiwan®, Ltd. is a process research, development, and manufacturing service provider of active pharmaceutical ingredients (APIs) to the global pharmaceutical industry. Our expertise is in small molecule custom synthesis. Click Here

Previous Headlines

>	CROs driving up drug costs, sa ...

>	Tandem teams up with Qualia ...

>	Xoma gets EU certification for ...

>	Ground Zero Pharma expands reg ...

>	Argos Therapeutics awarded HIV ...

>	Datatrak receives $3.3m from n ...

>	Bionomics selects SAFC to manu ...

>	Covalent Group bags $8.2m wort ...

>	LAB to acquire PharmaForm ...

>	Contract sales and marketing b ...

Product Categories

>	Product & Supplier News - Contract Manufacturing

Related Web Sites

>	In-PharmaTechnologist.com

>	DrugResearcher.com

>	BioPharmaReporter.com



>	All our Websites

Other top industry news

Novartis splashes the cash in Asia
Novartis is splashing its cash in Asia, intending to invest $100m (€79m) in China and INR5bn (€90m) in India to establish large new R&D centres... Read

MSD invests €100m in Irish drug making arm
Merck Sharp & Dohme has just announced a €100m investment in South Tipperary, Ireland to build a new formulation R&D centre and drug manufacturing plant... Read

Researchers use bacteria to make anti-cancer drugs
Scientists are looking into the possibility of using bacteria to make a new library of anti-cancer compounds... Read

Sigma-Aldrich launches first commercially available proteomics standard
Sigma-Aldrich launches the first commercially available proteomics standard in which allows researchers to better assess proteomics strategies... Read

Events - Publisher's Choice

STAY up-to-date with pharmaceutical Innovations
Visit our regularly updated events calendar and learn about important events within the industry today ... Read

ELNS & Laboratory Informatics
4 days of interactive sessions and case studies providing the most current assessment of the future of electronic data recording implementation, integ ... Read

Sponsored by SF-Chem
High-quality intermediates
SF-Chem is a supplier of high-quality intermediates to customers in the global chemical industry, particularly pharmaceuticals. The company is highly specialised in chlorine and sulfur chemistry. Click Here

Forward to a colleague

Subscribe to other Decision News Media e-newsletters - Pharmaceuticals

	To continue to receive this newsletter in your inbox, please add newsletter@outsourcing-pharma.com to your address book
	Update preferences \| Change your email address \| ***
	Contact us: Advertising \| Recruitment \| Privacy policy \| Terms & conditions \| Feedback
	© 2006 - Decision News Media S.A.S - All Rights Reserved La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France http://www.decisionnewsmedia.com

Back to newsletter list

Date:

From:

Subject:

08/11 Eastern Europe/Diosynth/eClinical/Aptuit/osteoarthritis